|
1
|
Buckner JC, Brown PD, O'Neill BP, Meyer
FB, Wetmore CJ and Uhm JH: Central nervous system tumors. Mayo Clin
Proc. 82:1271–1286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang R, Luo H, Wang S, Chen W, Chen Z,
Wang HW, Chen Y, Yang J, Zhang X, Wu W, et al: MicroRNA-377
inhibited proliferation and invasion of human glioblastoma cells by
directly targeting specificity protein 1. Neuro Oncol.
16:1510–1522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lukiw WJ, Cui JG, Li YY and Culicchia F:
Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and
caspase-3 accompanies down-regulation of the survivin-1 homolog
BIRC1 (NAIP) in glioblastoma multiforme (GBM). J Neurooncol.
91:27–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma-a critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
|
6
|
Linz U: Commentary on effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet
Oncol. 2009;10:459-466). Cancer. 116:1844–1846. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Louis DN: Molecular pathology of malignant
gliomas. Annu Rev Pathol. 1:97–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Q, Zhou L, Wang M, Wang N, Li C, Wang J
and Qi L: MicroRNA-613 impedes the proliferation and invasion of
glioma cells by targeting cyclin-dependent kinase 14. Biomed
Pharmacother. 98:636–642. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang B, Li M, Ji F and Nie Y:
MicroRNA-219 exerts a tumor suppressive role in glioma via
targeting Sal-like protein 4. Exp Ther Med. 14:6213–6221.
2017.PubMed/NCBI
|
|
13
|
Wang D, Zhi T, Xu X, Bao Z, Fan L, Li Z,
Ji J and Liu N: MicroRNA-936 induces cell cycle arrest and inhibits
glioma cell proliferation by targeting CKS1. Am J Cancer Res.
7:2131–2143. 2017.PubMed/NCBI
|
|
14
|
Zhou X, Wu W, Zeng A, Nie E, Jin X, Yu T,
Zhi T, Jiang K, Wang Y, Zhang J, et al: MicroRNA-141-3p promotes
glioma cell growth and temozolomide resistance by directly
targeting p53. Oncotarget. 8:71080–71094. 2017.PubMed/NCBI
|
|
15
|
Mao K, Lei D, Zhang H and You C:
MicroRNA-485 inhibits malignant biological behaviour of
glioblastoma cells by directly targeting PAK4. Int J Oncol.
51:1521–1532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Zhang J, Zhang J, Qiu W, Xu S, Yu
Q, Liu C, Wang Y, Lu A, Zhang J, et al: MicroRNA-625 inhibits the
proliferation and increases the chemosensitivity of glioma by
directly targeting AKT2. Am J Cancer Res. 7:1835–1849.
2017.PubMed/NCBI
|
|
17
|
Chen L, Wang W, Zhu S, Jin X, Wang J, Zhu
J and Zhou Y: MicroRNA-590-3p enhances the radioresistance in
glioblastoma cells by targeting LRIG1. Exp Ther Med. 14:1818–1824.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan B, Liang Y, Wang D and Luo F: MiR-940
inhibits hepatocellular carcinoma growth and correlates with
prognosis of hepatocellular carcinoma patients. Cancer Sci.
106:819–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu
Z, Tang W, Gan L, Sun M and Li J: MicroRNA-940 promotes tumor cell
invasion and metastasis by downregulating ZNF24 in gastric cancer.
Oncotarget. 6:25418–25428. 2015.PubMed/NCBI
|
|
20
|
Rajendiran S, Parwani AV, Hare RJ,
Dasgupta S, Roby RK and Vishwanatha JK: MicroRNA-940 suppresses
prostate cancer migration and invasion by regulating MIEN1. Mol
Cancer. 13:2502014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou L, Chen M, Yang H, Xing T, Li J, Li G,
Zhang L, Deng S, Hu J, Zhao X, et al: MiR-940 inhibited cell growth
and migration in triple-negative breast cancer. Med Sci Monit.
22:3666–3672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang F, Wang Z, Gu X and Cui J: miR-940
upregulation suppresses cell proliferation and induces apoptosis by
targeting PKC-δ in ovarian cancer OVCAR3 cells. Oncol Res.
25:107–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding D, Zhang Y, Yang R, Wang X, Ji G, Huo
L, Shao Z and Li X: miR-940 suppresses tumor cell invasion and
migration via regulation of CXCR2 in hepatocellular carcinoma.
Biomed Res Int. 2016:76183422016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Kwong A, Sihoe A and Chu KM: Plasma
miR-940 may serve as a novel biomarker for gastric cancer. Tumour
Biol. 37:3589–3597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z,
Zhao CL, Zhang XF and Ye H: Over-expression of microRNA-940
promotes cell proliferation by targeting GSK3β and sFRP1 in human
pancreatic carcinoma. Biomed Pharmacother. 83:593–601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McConnell BB and Yang VW: Mammalian
Krüppel-like factors in health and diseases. Physiol Rev.
90:1337–1381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mao Z, Fan X, Zhang J, Wang X, Ma X,
Michalski CW and Zhang Y: KLF9 is a prognostic indicator in human
pancreatic ductal adenocarcinoma. Anticancer Res. 37:3795–3799.
2017.PubMed/NCBI
|
|
29
|
Qiao F, Yao F, Chen L, Lu C, Ni Y, Fang W
and Jin H: Krüppel-like factor 9 was down-regulated in esophageal
squamous cell carcinoma and negatively regulated beta-catenin/TCF
signaling. Mol Carcinog. 55:280–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun J, Wang B and Liu Y, Zhang L, Ma A,
Yang Z, Ji Y and Liu Y: Transcription factor KLF9 suppresses the
growth of hepatocellular carcinoma cells in vivo and positively
regulates p53 expression. Cancer Lett. 355:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia
S, Wang Y, Liu Y and Shi G: KLF9, a transcription factor induced in
flutamide-caused cell apoptosis, inhibits AKT activation and
suppresses tumor growth of prostate cancer cells. Prostate.
74:946–958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bai XY, Li S, Wang M, Li X, Yang Y, Xu Z,
Li B, Li Y, Xia K, Chen H, et al: Krüppel-like factor 9
down-regulates matrix metalloproteinase 9 transcription and
suppresses human breast cancer invasion. Cancer Lett. 412:224–235.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mannava S, Zhuang D, Nair JR, Bansal R,
Wawrzyniak JA, Zucker SN, Fink EE, Moparthy KC, Hu Q, Liu S, et al:
KLF9 is a novel transcriptional regulator of bortezomib- and
LBH589-induced apoptosis in multiple myeloma cells. Blood.
119:1450–1458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang S, Wang C, Yi Y, Sun X, Luo M, Zhou
Z, Li J, Cai Y, Jiang X and Ke Y: Krüppel-like factor 9 inhibits
glioma cell proliferation and tumorigenicity via downregulation of
miR-21. Cancer Lett. 356:547–555. 2015. View Article : Google Scholar : PubMed/NCBI
|
